日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis

免疫分析揭示奥瑞珠单抗在早期复发缓解型多发性硬化症中的T细胞效应

Garcia, Alexandra; Dugast, Emilie; Shah, Sita; Morille, Jérémy; Lebrun-Frenay, Christine; Thouvenot, Eric; De Sèze, Jérôme; Le Page, Emmanuelle; Vukusic, Sandra; Maurousset, Aude; Berger, Eric; Casez, Olivier; Labauge, Pierre; Ruet, Aurélie; Raposo, Catarina; Bakdache, Fabien; Buffels, Régine; Le Frère, Fabienne; Nicot, Arnaud; Wiertlewski, Sandrine; Gourraud, Pierre-Antoine; Berthelot, Laureline; Laplaud, David

SAkuraBONSAI: Protocol design of a novel, prospective study to explore clinical, imaging, and biomarker outcomes in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder receiving open-label satralizumab

SAkuraBONSAI:一项新型前瞻性研究的方案设计,旨在探索接受开放标签沙曲珠单抗治疗的 AQP4-IgG 血清阳性视神经脊髓炎谱系障碍患者的临床、影像学和生物标志物结果

Bennett, Jeffrey L; Fujihara, Kazuo; Kim, Ho Jin; Marignier, Romain; O'Connor, Kevin C; Sergott, Robert C; Traboulsee, Anthony; Wiendl, Heinz; Wuerfel, Jens; Zamvil, Scott S; Anania, Veronica G; Buffels, Regine; Künzel, Thomas; Lekkerkerker, Annemarie N; Lennon-Chrimes, Siân; Pittock, Sean J

Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial

奥克瑞珠单抗治疗对既往疾病修饰疗法反应欠佳的复发缓解型多发性硬化症患者的疗效和安全性:来自 3b 期 CASTING 单臂、开放标签试验的主要分析

Vermersch, Patrick; Oreja-Guevara, Celia; Siva, Aksel; Van Wijmeersch, Bart; Wiendl, Heinz; Wuerfel, Jens; Buffels, Regine; Kadner, Karen; Kuenzel, Thomas; Comi, Giancarlo

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a

在接受奥瑞珠单抗治疗与接受干扰素β-1a治疗的复发型多发性硬化症患者中,按时期进行的无疾病活动证据(NEDA)分析

Havrdová, Eva; Arnold, Douglas L; Bar-Or, Amit; Comi, Giancarlo; Hartung, Hans-Peter; Kappos, Ludwig; Lublin, Fred; Selmaj, Krzysztof; Traboulsee, Anthony; Belachew, Shibeshih; Bennett, Iain; Buffels, Regine; Garren, Hideki; Han, Jian; Julian, Laura; Napieralski, Julie; Hauser, Stephen L; Giovannoni, Gavin

The International Primary Care Respiratory Group (IPCRG) Research Needs Statement 2010

国际基层呼吸系统疾病研究组(IPCRG)2010年研究需求声明

Pinnock, Hilary; Thomas, Mike; Tsiligianni, Ioanna; Lisspers, Karin; Østrem, Anders; Ställberg, Björn; Yusuf, Osman; Ryan, Dermot; Buffels, Johan; Cals, Jochen W L; Chavannes, Niels H; Henrichsen, Svein Høegh; Langhammer, Arnulf; Latysheva, Elena; Lionis, Christos; Litt, John; van der Molen, Thys; Zwar, Nick; Williams, Sian

Diagnostic certainty, co-morbidity and medication in a primary care population with presumed airway obstruction: the DIDASCO2 study

DIDASCO2 研究:初级保健人群中疑似气道阻塞患者的诊断确定性、合并症和用药情况

Buffels, Johan; Degryse, Jan; Liistro, Giuseppe

IPCRG Consensus statement: tackling the smoking epidemic - practical guidance for primary care

IPCRG共识声明:应对吸烟流行——基层医疗实用指南

van Schayck, Onno C P; Pinnock, Hilary; Ostrem, Anders; Litt, John; Tomlins, Ron; Williams, Siân; Buffels, Johan; Giannopoulos, Dimitri; Henrichsen, Svein; Kaper, Janneke; Korzh, Oleksiy; Rodriguez, Ana Morán; Kawaldip, Sehmi; Zwar, Nick; Yaman, Hakan

Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004

慢性阻塞性肺疾病进展评估:2004年3月11日至12日在鲁汶举行的研讨会报告

Decramer, M; Gosselink, R; Rutten-Van Mölken, M; Buffels, J; Van Schayck, O; Gevenois, P-A; Pellegrino, R; Derom, E; De Backer, W

Pharmacokinetic study of tenofovir disoproxil fumarate combined with rifampin in healthy volunteers

替诺福韦酯富马酸盐联合利福平在健康志愿者中的药代动力学研究

Droste, J A H; Verweij-van Wissen, C P W G M; Kearney, B P; Buffels, R; Vanhorssen, P J; Hekster, Y A; Burger, D M